Literature DB >> 25673042

An investigation of nifedipine miscibility in solid dispersions using Raman spectroscopy.

Sujinda Keratichewanun1, Yasuo Yoshihashi, Narueporn Sutanthavibul, Katsuhide Terada, Jittima Chatchawalsaisin.   

Abstract

PURPOSE: Raman spectroscopy is potentially an extremely useful tool for the understanding of drug-polymer interactions in solid dispersions. This is examined and demonstrated for the case of solid dispersions of nifedipine in a polymeric substrate.
METHODS: Solid dispersions consisting of nifedipine and polyvinyl caprolactam--polyvinyl acetate--polyethylene glycol graft copolymer (Soluplus®) were prepared by freeze drying, melting and solvent evaporation at drug loadings of 10, 30, 50, 70 and 90% w/w. Drug-polymer interactions in the amorphous solid dispersion were estimated by Raman spectroscopy. The correlation between the solid state stability of the drug in a solid dispersion and the extent of drug-polymer interaction was monitored by X-ray diffractometry.
RESULTS: The miscibility limit of nifedipine-Soluplus® was found to be 30% w/w drug loading for all preparation methods. The drug was found to interact with Soluplus®, through a hydrophilic interaction identified by infrared spectroscopy and a hydrophobic interaction which could be quantified by Raman spectroscopy. The average extent of the drug-polymer interaction in the studied amorphous samples at equivalent drug loading was similar, regardless of the preparation method. Inhomogeneities in samples prepared by melting contributed to a wider variation in drug-polymer interaction and poorer solid state stability, in terms of its crystallization tendency.
CONCLUSIONS: Raman spectroscopy was shown to be a useful technique in classifying miscibility levels based on the hydrophobic interaction between the drug and the polymer. Different drug loadings showed varying degrees of drug-polymer interaction, and hence variable solid state stability of the solid dispersion.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25673042     DOI: 10.1007/s11095-015-1638-x

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  28 in total

1.  Physical stability studies of miscible amorphous solid dispersions.

Authors:  Igor Ivanisevic
Journal:  J Pharm Sci       Date:  2010-09       Impact factor: 3.534

2.  Is a distinctive single Tg a reliable indicator for the homogeneity of amorphous solid dispersion?

Authors:  Feng Qian; Jun Huang; Qing Zhu; Raja Haddadin; John Gawel; Robert Garmise; Munir Hussain
Journal:  Int J Pharm       Date:  2010-05-24       Impact factor: 5.875

3.  Effects of preparing techniques and aging on dissolution behavior of the solid dispersions of NF/Soluplus/Kollidon SR: identification and classification by a combined analysis by FT-IR spectroscopy and computational approaches.

Authors:  Xiang Li; Chuan Jiang; Lili Pan; Haoyang Zhang; Lang Hu; Tianxue Li; Xinghao Yang
Journal:  Drug Dev Ind Pharm       Date:  2014-07-15       Impact factor: 3.225

4.  Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility.

Authors:  Patrick J Marsac; Sheri L Shamblin; Lynne S Taylor
Journal:  Pharm Res       Date:  2006-08-24       Impact factor: 4.200

5.  A spectroscopic investigation of hydrogen bond patterns in crystalline and amorphous phases in dihydropyridine calcium channel blockers.

Authors:  Xiaolin Charlie Tang; Michael J Pikal; Lynne S Taylor
Journal:  Pharm Res       Date:  2002-04       Impact factor: 4.200

6.  Characterisation of indomethacin and nifedipine using variable-temperature solid-state NMR.

Authors:  David C Apperley; Angus H Forster; Romain Fournier; Robin K Harris; Paul Hodgkinson; Robert W Lancaster; Thomas Rades
Journal:  Magn Reson Chem       Date:  2005-11       Impact factor: 2.447

7.  The potential of small-scale fusion experiments and the Gordon-Taylor equation to predict the suitability of drug/polymer blends for melt extrusion.

Authors:  A Forster; J Hempenstall; T Rades
Journal:  Drug Dev Ind Pharm       Date:  2001-07       Impact factor: 3.225

8.  A comparison of the physical stability of amorphous felodipine and nifedipine systems.

Authors:  Patrick J Marsac; Hajime Konno; Lynne S Taylor
Journal:  Pharm Res       Date:  2006-08-23       Impact factor: 4.200

9.  Evaluation of drug-polymer miscibility in amorphous solid dispersion systems.

Authors:  Alfred C F Rumondor; Igor Ivanisevic; Simon Bates; David E Alonzo; Lynne S Taylor
Journal:  Pharm Res       Date:  2009-09-22       Impact factor: 4.200

10.  Preparation of carbamazepine-Soluplus solid dispersions by hot-melt extrusion, and prediction of drug-polymer miscibility by thermodynamic model fitting.

Authors:  Jelena Djuris; Ioannis Nikolakakis; Svetlana Ibric; Zorica Djuric; Kyriakos Kachrimanis
Journal:  Eur J Pharm Biopharm       Date:  2013-01-18       Impact factor: 5.571

View more
  6 in total

1.  Insights into Nano- and Micron-Scale Phase Separation in Amorphous Solid Dispersions Using Fluorescence-Based Techniques in Combination with Solid State Nuclear Magnetic Resonance Spectroscopy.

Authors:  Hitesh S Purohit; James D Ormes; Sugandha Saboo; Yongchao Su; Matthew S Lamm; Amanda K P Mann; Lynne S Taylor
Journal:  Pharm Res       Date:  2017-04-28       Impact factor: 4.200

2.  Impact of Drug-Polymer Miscibility on Enthalpy Relaxation of Irbesartan Amorphous Solid Dispersions.

Authors:  Sonu Dalsania; Jagadish Sharma; Bhushan Munjal; Arvind K Bansal
Journal:  Pharm Res       Date:  2018-01-09       Impact factor: 4.200

3.  Physical Stability and Dissolution of Lumefantrine Amorphous Solid Dispersions Produced by Spray Anti-Solvent Precipitation.

Authors:  Sonal V Bhujbal; Vaibhav Pathak; Dmitry Y Zemlyanov; Lynne S Taylor; Qi Tony Zhou
Journal:  J Pharm Sci       Date:  2020-12-31       Impact factor: 3.534

4.  Co-Amorphous Simvastatin-Nifedipine with Enhanced Solubility for Possible Use in Combination Therapy of Hypertension and Hypercholesterolemia.

Authors:  Cecilia Martínez-Jiménez; Jorge Cruz-Angeles; Marcelo Videa; Luz María Martínez
Journal:  Molecules       Date:  2018-08-28       Impact factor: 4.411

5.  Formulating a heat- and shear-labile drug in an amorphous solid dispersion: Balancing drug degradation and crystallinity.

Authors:  Daniel A Davis; Dave A Miller; Supawan Santitewagun; J Axel Zeitler; Yongchao Su; Robert O Williams
Journal:  Int J Pharm X       Date:  2021-07-17

6.  Molecular Disorder of Bicalutamide-Amorphous Solid Dispersions Obtained by Solvent Methods.

Authors:  Joanna Szafraniec; Agata Antosik; Justyna Knapik-Kowalczuk; Karolina Gawlak; Mateusz Kurek; Jakub Szlęk; Witold Jamróz; Marian Paluch; Renata Jachowicz
Journal:  Pharmaceutics       Date:  2018-10-18       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.